Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Scilex Holding Company

SCLX
0,5092
0,0047 (0,93%)
18 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/12/202415:00GLOBEScilex Holding Company Announces Early Installment Payment..
13/12/202418:23GLOBEScilex Holding Company Announces Closing of $17 Million..
12/12/202414:21GLOBEScilex Holding Company Announces $17 Million Registered..
11/12/202418:49GLOBEScilex Bio, a Controlling Interest of Joint Venture by..
11/12/202413:30GLOBEScilex Bio, a Controlling Interest of Joint Venture by..
10/12/202413:00GLOBEScilex Holding Company Enters into a Binding Term Sheet for..
22/11/202412:00GLOBEScilex Holding Company Announces Receipt of Notice from..
15/11/202415:00GLOBEScilex Holding Company Announces Presentation of Data at the..
11/11/202423:01GLOBEDenali Capital Acquisition Corp. Announces Extension of..
06/11/202418:24GLOBESemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of..
30/10/202411:00GLOBEScilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of..
29/10/202411:00GLOBEScilex Holding Company, Following its Prior Announcement of..
28/10/202411:00GLOBEScilex Holding Company sets November 7, 2024 as the Record..
16/10/202419:40APSHolding Company Shares Rally Following Board Of Directors..
16/10/202413:00GLOBEScilex Holding Company Announces that its Board of Directors..
16/10/202410:00GLOBESemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of..
08/10/202419:58GLOBEScilex Holding Company Provides Certain Preliminary..
08/10/202417:50GLOBEScilex Holding Company Announces Closing of a $50 Million..
07/10/202415:52GLOBEScilex Holding Company Announces Signing of a $50 Million..
26/9/202415:00GLOBEScilex Holding Company Announces that the U.S. Bankruptcy..
18/9/202415:00GLOBEScilex Holding Company Announces the Continuing Support from..
12/9/202415:00GLOBEScilex Holding Company Announces It Has Received the Drug..
09/9/202415:00GLOBEScilex Holding Company to Present at the 26th Annual H.C...
05/9/202415:00GLOBEScilex Holding Company Announces Acceptance of Presentation..
03/9/202415:24EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/9/202415:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/9/202415:08EDGAR2Form 425 - Prospectuses and communications, business..
03/9/202415:06EDGAR2Form 8-K - Current report
03/9/202415:00GLOBESemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of..
30/8/202415:00GLOBEScilex Holding Company to Present Oral, Poster Presentations..
29/8/202415:00GLOBEScilex Holding Company Announces FDA Final Approval to..
21/8/202415:00GLOBEScilex Holding Company Announces the U.S. Patent and..
19/8/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:34EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/8/202422:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/8/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202423:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/8/202415:00GLOBEScilex Holding Company Enters into Master Distributor..
01/8/202415:00EDGAR2Form 8-K - Current report
01/8/202415:00GLOBEScilex Holding Company Provides Certain Preliminary..
26/7/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/7/202403:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/7/202423:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/7/202423:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/7/202423:19EDGAR2Form 8-K - Current report
24/7/202416:52GLOBEScilex Holding Company Announces Publication of Its..
23/7/202415:00GLOBEScilex Holding Company Strengthens Board of Directors with..
18/7/202422:20EDGAR2Form S-3 - Registration statement under Securities Act of..
17/7/202415:00GLOBEScilex Holding Company Announces Collaboration to Leverage..
08/7/202419:53EDGAR2Form 8-K - Current report
Apertura: 0,51 Min: 0,49 Max: 0,5399
Chiusura: 0,5045

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network